MediKredit’s Pharmaceutical Benefit Management (PBM) service, coupled with our integrated chronic medicine management programme, provides healthcare funder beneficiaries with access to clinically appropriate, cost-effective treatment.

This in turn ensures that expenditure on medicines is strictly managed to avoid unnecessary costs and/or utilisation for healthcare funder clients, including medical schemes, and their valued beneficiaries.

Key components of our PBM service include:

• Development and maintenance of evidence-based protocols
• Pharmacy Advised Therapy (PAT) and acute medicines management
• Pre-authorisation and Drug Utilisation Review (DUR) for chronic and high-cost medicines
• PBM application on medicine claims adjudication and management
• Reporting on a medical scheme’s performance related to PBM services
• Prescribed Minimum Benefit (PMB) compliance and management
• Flexible and customisable generic and therapeutic reference pricing systems